Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 41

Trial Status

Completed4
Other2

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT06301529Phase 4Completed
The Efficacy and Tolerability of Canagliflozin in Healthy Individual
Healthy Aging
PrincipalinvestigatorStart date: 2024-02-12
NCT05307627Withdrawn
The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging
Aging
PrincipalinvestigatorStart date: 2022-03-14
NCT04604704Phase 2Completed
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
Covid19Long COVID-19Post-COVID-19 Syndrome
PrincipalinvestigatorStart date: 2021-01-28

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06301529Phase 4PrincipalInvestigator

The Efficacy and Tolerability of Canagliflozin in Healthy Individual

Healthy Aging
Completed
NCT06550271StudyDirector

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

Aging
Completed
NCT05307627PrincipalInvestigator

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Aging
Withdrawn
NCT04604704Phase 2PrincipalInvestigator

Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome

Covid19Long COVID-19Post-COVID-19 Syndrome
Completed
NCT04488601Phase 2StudyDirector

Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

Aging
Completed
NCT04604678Phase 2PrincipalInvestigator

Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

Covid19
Withdrawn

All 6 trials loaded